MetLife Investment Management’s United States Antimony UAMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Buy
78,490
+17,208
+28% +$156K ﹤0.01% 1836
2026
Q1
$535K Sell
61,282
-5,719
-9% -$49.9K ﹤0.01% 1730
2025
Q4
$336K Buy
67,001
+12,721
+23% +$99.9K ﹤0.01% 1991
2025
Q3
$337K Sell
54,280
-2,546
-4% -$10.6K ﹤0.01% 2019
2025
Q2
$124K Buy
+56,826
New +$161K ﹤0.01% 2433

Other funds holding UAMY

MetLife Investment Management's UAMY Position: Q2 2026 in Review

MetLife Investment Management increased its United States Antimony (UAMY) stake by 28% in Q2 2026, buying an estimated $156K and bringing the position to 78,490 shares worth $570K. The position accounts for ﹤0.01% of the portfolio, ranked #1836.

MetLife Investment Management first reported a position in UAMY in Q2 2025 and has held it in 5 quarters since. 238 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

  • MetLife Investment Management held 78,490 shares of United States Antimony worth $570K as of Q2 2026.
  • MetLife Investment Management bought 17,208 United States Antimony shares in Q2 2026, an estimated $156K.
  • United States Antimony made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1836 holding.
  • MetLife Investment Management first reported a position in United States Antimony in Q2 2025 and has held it in 5 quarters since.
  • 238 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.